Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir
S. Safrin, T. Schacker, J. Delehanty, E. Hill, L. Corey
Dive into the research topics of 'Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir'. Together they form a unique fingerprint.